ECONCARE

Name

ECONCARE

Legal name

ΕΚΟΝΚΕΡ ΥΠΗΡΕΣΙΕΣ ΕΠΙΧΕΙΡΗΜΑΤΙΚΩΝ ΣΥΜΒΟΥΛΩΝ Ε.Ε. (ECONCARE BUSINESS ADVISORY SERVICES LP)

Website

https://econcare.gr

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Health Economics & Outcomes Research (HEOR) Consulting

NAICS

Management, Scientific, and Technical Consulting Services (5416)

akta.pro primary industry

Health Economics & Outcomes Research (HEOR) (HLAIAKAB)

Keywords

• Health economics consulting
• Outcomes research services
• Market access strategy
• Clinical research services
• Health technology assessment

Headquarters

HQ city

Athens

HQ country

Greece

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Consulting Services: Professional consulting services in health economics, outcomes research, market access, pricing and reimbursement, biostatistics, epidemiology, HTA, medical writing, and regulatory affairs. Revenue generated through project-based consulting engagements with pharmaceutical companies, healthcare organizations, insurers, and government agencies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

ECONCARE is a health economics and outcomes research (HEOR) consulting firm delivering project-based advisory services to pharmaceutical and biotechnology companies, healthcare providers, insurers, and government agencies. Its portfolio spans economic evaluation studies, real-world evidence generation, evidence synthesis, market access and pricing/reimbursement strategy, modeling and analytics, clinical research support (Phase I-IV), and tailored training for the life-science industry.

Product overview

ECONCARE is a health research and consulting company offering a comprehensive suite of services as a unified portfolio rather than a software platform. The core offerings include Health Economic & Outcomes Research (HEOR), Market Access & Commercial Strategy, Modelling & Analytics, Clinical Research & Development, and Training services. These services work together to help life sciences companies communicate the value of their products for healthcare regulation and pricing/reimbursement purposes. ECONCARE conducts economic evaluations, real-world evidence studies, budget impact analyses, and cost-effectiveness research to support market access and policy decisions in Greece and internationally.

Differentiator

Problem solved

Functional benefit

Products and services

• Health Economic & Outcomes Research (HEOR) Comprehensive consulting services in health economics and outcomes research for pharmaceutical and biotechnology clients, delivering economic evaluation studies, real-world evidence generation, and evidence synthesis across the product development continuum.
• Market Access, Commercial Strategy & Implementation Strategic consulting encompassing payer/provider/stakeholder research, evidence dossiers and communication tools, value proposition and evidence strategy, integrated pricing & reimbursement and managed entry agreements strategies, and policy & regulation analysis to protect and expand product commercial success.
• Modelling & Analytics Forecasting and modelling services that integrate product profiles, landscape assessments, and stakeholder research to guide business decisions and strategic planning for life-sciences clients.
• Clinical Research & Development Full-service CRO support for Phase I-IV clinical trials and medical device programs, providing end-to-end project implementation from early phase to post-authorization studies for pharmaceutical and medical device clients.
• Training, Up-Skilling & On-Boarding Tailor-made targeted training programs across a broad range of health-economic topics and disease areas, designed to increase productivity, reduce quality issues and maintain compliance with industry regulations for healthcare and life-science clients.

Quantifiable outcome

• Multiple studies published in peer-reviewed journals and presented at ISPOR conferences (Top 5% award finalists in 2022, 2024, 2025)

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• UCBcoreStrategic or Co-development Partner · 20 February 2024ECONCARE conducted a comprehensive research study on 'Psoriatic Arthritis & Axial Spondyloarthritis: The Burden of Disease and Patient Journey in Greece (2024)' in collaboration with UCB, a pharmaceutical company.
• ΡευΜΑζην (Panhellenic Federation of Patient, Parent, Guardian, and Friend Associations of Children with Rheumatic Diseases)coreStrategic or Co-development PartnerCollaboration with ΡευΜΑζην for conducting patient burden of disease and patient journey research in Greece.
• International Consulting FirmsminorOthersECONCARE collaborates with large international consulting firms on various projects.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• BresMed: BresMed is a specialized HEOR and market access consulting firm serving pharmaceutical and medical device clients. Its health economics, modelling, and evidence synthesis focus closely mirrors ECONCARE's core HEOR offerings.
• Syneos Health: Syneos Health combines clinical research services with HEOR, market access, and commercial consulting, offering an integrated CRO-plus-evidence value proposition similar to ECONCARE's full-service model.
• Evidera (PPD / Thermo Fisher Scientific): Evidera is a dedicated HEOR, market access, real-world evidence, and patient-centered research consulting firm now part of Thermo Fisher's PPD. It is one of the closest direct competitors to ECONCARE, providing overlapping services to pharma across therapeutic areas.
• ICON plc: ICON is a global CRO with a dedicated HEOR, market access, and real-world evidence consulting practice, serving pharmaceutical and biotech clients across the product lifecycle. It competes with ECONCARE for enterprise pharma HEOR engagements while operating at much greater scale.
• Mtech Access: Mtech Access is a UK-based boutique HEOR, market access, and evidence synthesis consultancy. It is comparable to ECONCARE as a similarly sized specialist firm offering overlapping HEOR and market access services to pharma clients.
• Cytel: Cytel provides biostatistics, HEOR, and real-world evidence consulting to pharma and biotech clients. Its biostatistics-and-health-economics overlap with ECONCARE's offerings makes it a natural peer, especially for evidence-generation and modelling work.
• Putnam Associates: Putnam Associates provides market access, pricing, and commercial strategy consulting to pharmaceutical clients. Its market-access and pricing strategy focus overlaps with ECONCARE's Market Access, Commercial Strategy & Implementation offering.
• OPEN Health Group: OPEN Health is a global HEOR, market access, and medical communications consulting group that acquired Pharmerit. It offers an integrated HEOR-and-market-access value proposition very similar to ECONCARE's full-stack service model.

Broad incumbents

• Charles River Associates: CRA's Life Sciences practice provides strategic management consulting including HEOR, pricing, and market access advisory. It serves overlapping pharmaceutical clients but as part of a broader economic and management consulting portfolio.
• IQVIA: IQVIA is the largest life sciences services firm with an extensive Real World Solutions HEOR and market access practice. It serves the same pharmaceutical client base as ECONCARE but at global scale and as part of a broader data, technology, and consulting portfolio.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/econcare

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ECONCARE